13.26USD+0.30%Mkt Cap: 1.26B USDP/E: —Last update: 2026-05-26
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers cli…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap1.26B USD
Enterprise Value2.21B USD
Revenue (TTM)2.71B USD
Gross Profit503.80M USD
Net Income (TTM)-986.20M USD
Revenue/Share29.42 USD
Last Price13.26 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees14.0K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)12.21
PEG0.34
EV/EBITDA31.68
EV/Revenue0.82
P/S0.46
P/B2.17
EPS (TTM)-4.81
EPS (Forward)1.08
52W Range
3.97063% of range18.67
52W High18.67 USD
52W Low3.970 USD
Profitability
Gross Margin18.50%
Oper. Margin0.52%
EBITDA Margin2.58%
Profit Margin-36.21%
ROE-175.01%
ROA-36.31%
Growth
Revenue Growth-2.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF113.50M USD
CapEx (TTM)25.20M USD
FCF Margin10.54%
FCF Yield22.74%
Net Debt971.10M USD
Net Debt/EBITDA13.89
Balance Sheet
Debt/Equity1.98
Current Ratio0.95
Quick Ratio0.83
Book Value/Sh6.053 USD
Cash/Share1.559 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.3 (Buy)
Target (Mean)16.21 USD
Target Range9.500 USD – 20.00 USD
# Analysts11
Ownership
Shares Out.94.58M
Float93.90M
Insiders0.82%
Institutions110.04%
Short Interest
Short Ratio8.8d
Short % Float13.12%
Short % Out.11.16%
Shares Short10.56M
Short (prev mo.)10.31M
Technical
SMA 5011.06 (+19.9%)
SMA 20011.74 (+13.0%)
Beta1.91
S&P 52W Chg28.31%
Avg Vol (30d)1.40M
Avg Vol (10d)1.09M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—